Learn more

ELSTAR THERAPEUTICS INC

Overview
  • Total Patents
    48
  • GoodIP Patent Rank
    31,480
  • Filing trend
    ⇧ 58.0%
About

ELSTAR THERAPEUTICS INC has a total of 48 patent applications. It increased the IP activity by 58.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ORIONIS BIOSCIENCES INC, F STAR BETA LTD and NANJING LEADS BIOLABS CO LTD.

Patent filings per year

Chart showing ELSTAR THERAPEUTICS INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Biotechnology
#3 Foods and drinks

Top inventors

# Name Total Patents
#1 Loew Andreas 48
#2 Vash Brian Edward 32
#3 Maiocco Stephanie J 18
#4 Vash Brian 15
#5 Maiocco Stephanie 9
#6 Hsu Jonathan 7
#7 Tan Seng-Lai 7
#8 Lamberto Ilaria 5
#9 Katragadda Madan 4
#10 Malhotra Nidhi 4

Latest patents

Publication Filing date Title
WO2020172601A1 Multifunctional molecules that bind to calreticulin and uses thereof
WO2020172596A1 Anti-tcr antibody molecules and uses thereof
WO2020172571A1 Multifunctional molecules that bind to t cell related cancer cells and uses thereof
WO2020172598A1 Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders
WO2020172605A1 Antibody molecules that bind to nkp30 and uses thereof
WO2020142672A2 Anti-tcr antibody molecules and uses thereof
WO2020069372A1 Csf1r/ccr2 multispecific antibodies
AU2019297451A1 Anti-TCR antibody molecules and uses thereof
EP3765517A1 Multifunctional molecules that bind to calreticulin and uses thereof
EP3765516A2 Multifunctional molecules and uses thereof
WO2019139987A1 Calreticulin binding constructs and engineered t cells for the treatment of diseases
WO2019113464A1 Multispecific molecules and uses thereof
WO2019035938A1 Multispecific molecules that bind to bcma and uses thereof
EP3630836A1 Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
AU2018260545A1 Multispecific molecules comprising a non-immunoglobulin heterodimerization domain and uses thereof
AU2018256406A1 Multispecific molecules and uses thereof
US2020291089A1 Multifunctional molecules comprising a trimeric ligand and uses thereof
EP3515936A1 Multispecific antibody molecules comprising lambda and kappa light chains
AU2017238172A1 Multispecific and multifunctional molecules and uses thereof